PETMED EXPRESS INC — Form 8-K
Filed August 12, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
PetMed Express amended its 2024 Omnibus Incentive Plan effective August 11, 2026, contingent on shareholder approval at the 2026 annual meeting. The amendment increases the number of shares reserved for issuance under the Plan. The original Plan reserved 2,650,000 shares plus 805,903 shares from prior plans, plus shares from a 2016 plan that become available. No specific new reserve amount is stated in this filing.
Why this rating
Amendment is routine governance; specific new share count not disclosed. At $46M market cap, equity dilution magnitude unclear but appears administrative rather than transformational.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.